Your browser doesn't support javascript.
loading
Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-).
Hu, Liping; Fan, Mengmeng; Shi, Shengmin; Song, Xiaomeng; Wang, Fei; He, Huan; Qi, Baohui.
  • Hu L; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, Guangdong Province, China.
  • Fan M; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, Guangdong Province, China.
  • Shi S; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, Guangdong Province, China.
  • Song X; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, Guangdong Province, China.
  • Wang F; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, Guangdong Province, China.
  • He H; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, Guangdong Province, China. Electronic address: hehuan_1029@163.com.
  • Qi B; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, Guangdong Province, China. Electronic address: bhqi@zmu.gd.cn.
Eur J Med Chem ; 227: 113963, 2022 Jan 05.
Article en En | MEDLINE | ID: mdl-34749202
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article